1. Decreased Proopiomelanocortin mRNA in Lymphocytes of Chronic Alcoholics After Intravenous Human Corticotropin Releasing Factor Injection.
- Author
-
Peter Rosenberger, Eckhard Mühlbauer, Thomas Weissmüller, Hans Rommelspacher, Pranav Sinha, Klaus D. Wernecke, Ulrich Finckh, Jordan Rettig, Wolfgang J. Kox, and, and Claudia D. Spies
- Subjects
ALCOHOLISM ,NEUROENDOCRINOLOGY ,PROOPIOMELANOCORTIN ,HORMONE resistance ,MESSENGER RNA - Abstract
SUMMARY: BACKGROUND Alcohol abuse may involve an altered neuroendocrine response that mediates lymphocyte-derived proopiomelanocortin (POMC) production and inflammation. We investigated POMC messenger RNA (mRNA) expression in human lymphocytes ex vivo and their relation to plasma ACTH and immunoreactive β-endorphin (IR-β-EP) after intravenous injection of human corticotropin releasing factor (hCRF) in chronic alcoholics (n = 12) and nonalcoholics (n = 12) before surgery. Lipopolysaccharide-stimulated interleukin (IL)-1 receptor antagonist (IL-1 Ra) as a marker for chronic inflammation was determined.METHODS Chronic alcohol abuse was diagnosed according to DSM-IV criteria and alcohol consumption >60 g/day. A reverse transcription-polymerase chain reaction method with total RNA and subsequent solid phase minisequencing was used to quantify lymphocytic POMC mRNA after intravenous hCRF injection. Plasma ACTH, cortisol, and lipopolysaccharide-stimulated IL-1 Ra of monocytes were measured by enzyme-linked immunosorbent assay, and plasma IR-β-EP was measured by using radioimmunoassay.RESULTS Baseline values of POMC mRNA content in lymphocytes and IL-1 Ra of chronic alcoholics were significantly increased compared with nonalcoholics (p < 0.01). Thirty minutes after intravenous hCRF injection, a significant increase of lymphocytic POMC mRNA was measured (p < 0.05) in nonalcoholics, whereas in chronic alcoholics a significant decrease was observed (p < 0.05).CONCLUSIONS Chronic alcoholic patients had an altered neuroendocrine immune axis before intravenous hCRF administration and were not able to adjust to intravenous CRF injection by increasing lymphocytic POMC mRNA expression. [ABSTRACT FROM AUTHOR]
- Published
- 2003
- Full Text
- View/download PDF